Chemicals / Complex Chemical Agents/ Chemical:
Ribavirin

INFORMATION AVAILABLE

GENERAL CHEMICAL INFORMATION THERAPEUTIC INFORMATION [DOSE, FREQUENCY & ROUTE]

NUTRITIONAL INFORMATION

TOXICITY INFORMATION ENVIRONMENTAL INFORMATION
Information in this page has been entered to support the current volumes of Wildpro and further information will be added as new volumes are completed. This page is not intended to substitute for the manufacturer's data sheet and the information is not yet complete for all species, or for all contra-indications etc.

CAUTION: Before any pharmaceutical product is used, the manufacturer's data sheet, containing information on uses, dosage and administration, contra-indications, warnings etc., should always be consulted. It is important to remember that licensing of pharmaceutical products for use in a particular species/condition, as well as mandatory meat and milk withdrawal times for food-producing animals, varies between countries and changes with time. Withdrawal times also may vary between different pharmaceutical formulations and depending on route of administration. In Europe the prescription cascade must be followed. In the USA FARAD may be consulted regarding residues and meat and milk withdrawal times.

General Chemical Information

Summary 
Nucleoside analogue active against RNA as well as DNA viruses.

Return to Top of Page

Names and Formulae
Type Antiviral . (B135.49.w49)
Alternative Names Ribofuranosyl-triazolecarboxamide. (B135.49.w49)
Chemical Formula --
Chemical Structure --
Molecular Weight --
Related Chemicals --

Return to Top of Page

Physical Properties / Chemistry
Appearance

--

Melting point --
Boiling point --
Density --
Water solubility --
Other solubility --
Acid/Base --

Return to Top of Page

Pharmacology & General Information
Pharmacology --
Storage / Stability --
Legal Category (In UK) --

Return to Top of Page

References

Associated Techniques

--

ORGANISATIONS

--

ELECTRONIC LIBRARY
(Further Reading)
Click image for full contents list of ELECTRONIC LIBRARY

--
Authors Debra Bourne (V.w5)
Referees Suzanne I. Boardman (V.w6)

Return to Top of Page

Therapeutic Information

Uses/Indications
Activity Interferes with formation of guanosine monophosphate and subsequent synthesis of nucleic acids. (B135.49.w49)
Appropriate Use --
Limitations --
Notes --

Return to Top of Page

Pharmacokinetics and Drug Interactions
Absorption /Bioavailability --
Distribution --
Plasma Protein binding / Storage --
Elimination Route --
Elimination half-life / Clearance Rate --
Drug Interactions --

Return to Top of Page

Administration
Formulations available --
Doses / Administration Routes / Frequencies --
Monitoring parameters --

Return to Top of Page

Withdrawal period / Withholding time
Notes --

Return to Top of Page

Toxic Information

Toxic effects of Pharmaceutical Products
Contraindications / Precautions --
Adverse Effects / Side Effects / Warnings --
Operator Warnings --
Overdose / Acute Toxicity --

Return to Top of Page

Detailed Toxicological Information
Classification --
Acute Toxicity --
Chronic Toxicity --
Reproductive effects --
Teratogenic effects --
Mutagenic effects --
Carcinogenic effects

--

Organ toxicity --
Bird Toxicity --
Aquatic organism activity --
Other organism toxicity --

Return to Top of Page

Nutrient Information

Nutritional Data
Sources --
Biological Use --
Recommended Daily Allowance / Recommended level in food --
Stability in food (Storage time) --
Interactions --

Return to Top of Page

External / Environmental Information

External / Environmental Uses
Use --
Formulation --
Application method --
Application Concentration --
Persistence of Effect / Frequency of Application --

Return to Top of Page

Sources in the Environment
Natural sources --
Human-associated sources

--

Return to Top of Page

Effects on the Environment
Effects in the aquatic environment

--

Effects on land --

Return to Top of Page

Persistence in the Environment
Breakdown in soil and groundwater

--

Breakdown in water --
Breakdown in vegetation --

Return to Top of Page